Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries has informed BSE that its trading window for dealing in company securities will be closed from 1st October 2025 until 48 hours after the declaration of unaudited financial results for the quarter ended 30th September 2025. This closure is in line with SEBI's Insider Trading Regulations and the company's own code of conduct to prevent insider trading during periods when financial results are being finalised. The exact date of the board meeting to approve these Q2 results has not yet been announced and will be communicated later.
This is a routine regulatory compliance filing and does not directly affect the stock price. It signals that the company's Q2 FY2026 (July-September 2025) earnings announcement is expected within October 2025, which investors should watch for as it may influence share price movement.